Il 12 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Il 12. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Il 12 Today - Breaking & Trending Today

Sequence Study of Risankizumab vs Ustekinumab in CD

David Rubin, MD, leads the panel discussion on a head-to-head sequence study of rizankizumab vs ustekinumab in the treatment of CD, as well as approaches to choosing first-line treatment. ....

Marla Dubinsky , David Rubin , Miguel Regueiro , Remo Panaccione , Sara Horst , Crohn X27s Disease , Il 12 , Il 23 , First Line Treatment ,

UNIFI Long-Term Extension Shows Safety, Efficacy of Ustekinumab for Ulcerative Colitis Through 4 Years

Results confirmed the long-term efficacy of ustekinumab maintenance in patients with ulcerative colitis, demonstrating consistent rates of symptomatic remission and endoscopic improvement with no new safety signals. ....

Waqqas Afif , Media Center , Drug Administration , Mcgill University , Inflammatory Bowel Disease Questionnaire , Ulcerative Colitis Through , Final Results , Severely Active Ulcerative , Maintenance Ustekinumab , Ulcerative Colitis , Interleukin 23 , Il 23 , Il 12 , Inflammatory Bowel Disease , Crohn X27s Disease ,

'Masked' Cancer Drug Kills Tumors While Sparing Healthy Tissue, Early Results Show

Many cancer treatments are notoriously savage on the body. Drugs often attack both healthy cells and tumor cells, causing a plethora of side effects. ....

Pritzker School , Molecular Engineering , Il 12 ,